Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
20,679,487
-
Shares change
-
+3,151,453
-
Total reported value, excl. options
-
$303,862,789
-
Value change
-
+$45,411,611
-
Number of buys
-
19
-
Number of sells
-
-28
-
Price
-
$14.70
Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q1 2020
62 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock as of Q1 2020.
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,679,487 shares
of 94,179,674 outstanding shares and own 22% of the company stock.
Largest 10 shareholders include FMR LLC (3,438,300 shares), Vivo Capital, LLC (3,320,801 shares), PERCEPTIVE ADVISORS LLC (2,587,953 shares), ORBIMED ADVISORS LLC (2,039,282 shares), RA CAPITAL MANAGEMENT, L.P. (1,961,209 shares), 5AM Venture Management, LLC (1,862,286 shares), EVENTIDE ASSET MANAGEMENT, LLC (947,000 shares), BlackRock Inc. (722,303 shares), VANGUARD GROUP INC (508,217 shares), and JANUS HENDERSON GROUP PLC (491,691 shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.